NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Analyst Ratings
NASDAQ:NMTC - Nasdaq - US64130M2098 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to NMTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.48. This target is 140.1% above the current price.
NMTC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NMTC.
In the previous month the buy percentage consensus was at a similar level.
NMTC was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-05 | Ladenburg Thalmann | Initiate | Buy |
| 2023-08-15 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2021-12-03 | Alliance Global Partners | Initiate | Buy |
| 2021-11-15 | Craig-Hallum | Initiate | Buy |